ALB and cancer: Permission is authorized for the adaptation of figures from our previously published open access articles entitled Amphiphilic albumin-based nanoparticles designed for the efficient delivery of taxanes and Acetyl-lysine human serum albumin nanoparticles activate CD44 receptors, with preferential uptake by cancer stem cells, leading to tumor eradication, which are distributed under the terms of the Creative Commons Attribution (CC BY) license.